Article | August 15, 2024

Improving Patient Outcomes With Wearables In Major Depressive Disorder

Source: ActiGraph

By Christine Guo, Ph.D.

Depression-gettyimages-1309050890

Incorporating new technology into drug development and clinical practice should always begin with the patients. This principle guided the New England Journal of Medicine (NEJM) editorial team as they structured their recent series on the clinical applications of wearable digital health technologies. Each article in the series begins with a real clinical case where wearable data was instrumental in patient care. For those who work primarily with wearable data behind a computer screen, these cases provide a powerful reminder of the real-world impact of their efforts.

The second article in the series focuses on the use of wearable data in treating major depressive disorder (MDD). It begins by highlighting the limitations of self-reported data, which is often biased and burdensome for patients, particularly in conditions like MDD where cognitive function may be impaired. Wearable data offers a solution by providing continuous, passive data collection in a patient’s daily life, thus capturing valuable, objective insights that can significantly enhance our understanding and treatment of this challenging condition.

Learn more by accessing the full article below.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader